- 66% BLUE LIGHT PROTECTION: prevents melasma recurrences(1) and significantly reduces modified Melasma Area Severity Index (mMASI) by almost a third*(2)
- SUN ACTIVE DEFENSE: high-technology sun protection(3) reinforced against UVAs (4)
- Sweat resistant(5)
- Clarifies existing dark spots thanks to Glabridin(2)
- 8h mattifying(6) and powdery finish(7)
- Perfectly covers hyperpigmentation marks for 98% of the users without mask effect(7)
Very good cutaneous and ocular tolerance(2,9) - Non-comedogenic(8) - Gel-cream texture - Non-sticky- Non-greasy - Unfragranced
Suitable for pregnant and breastfeeding women.
Exists in Claire, Dorée and Brun tints
Clinically tested on patients with phototype III to IV, melasma, pregnancy mask and pigment spots.
* p≤0.001, Student T-test, at D140 vs D0
(1)Assessment of the protective effect on visible light induced pigmentation of Photoderm M SPF50+ Brun - 20 healthy volunteers (aged 18-49 years) with phototype IIIb to V after 3 days of exposure to visible light. 2021
(2)Clinical study to evaluate the skin tolerance and efficacy to prevent worsening of melisma of Photoderm M SPF50+ Brun - 46 subjects included with Phototype IV to V.Brazil. 2021
(3)Evaluation of solar protection factor (SPF) (based on Standard ISO 24444) of Photoderm M SPF50+ Brun - 10 volunteers (aged 29-59 years). Italy.2021
(4)Evaluation of UVA Protection Factor of Photoderm M SPF50+ Brun - 10 volunteers (aged 18-43 years).Canada.2020
(5)Evaluation of sweat resistance properties of Photoderm M SPF50+ Brun - 10 volunteers (aged 29-59 years).Italy2021
(6)Evaluation of the mattifying effect of Photoderm M SPF50+ Brun on combination to oily skin after one standard application on the forehead, immediately and after 8 hours– 11 volunteers (aged 38-67 years) with combination to oily shine-prone skin on the forehead. 2021
(7)Evaluation of non-comedogenic effect of Photoderm M teinte claire, Photoderm M teinte dorée and Photoderm M teinte foncée as well as to verify its dermatological compatibility and acceptability, after application under the normal conditions of use – 106 patients (aged 25 to 45 years) with sensitive skin on the face and with phototype II to IV and melisma. South Africa.2021
(8)Evaluation of the non-comedogenicity, compatibility and acceptability of Photoderm M SPF50+ Brun after application under the normal conditions of use – 30 patients (aged 19-40 years) with combination to oily prone to acne skin on the face and with phototype IV.Portugal.2021
(9)Evaluation of the cutaneous and ocular acceptability of Photoderm M SPF50+ Brun – 11 patients (aged 26-43 years) with melasma and sensitive skin, with dry to oily skin. Mauritius.2021